The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day

Drug and Alcohol Dependence

Volumn 93, Issue 1-2, 2008, Pages 132-140

  Somoza, Eugene ^a,b,c   Somoza, Peggy ^b   Lewis, Daniel ^b   Li, Shou Hua ^d   Winhusen, Theresa ^a,b   Chiang, Nora ^d   Vocci, Frank ^d   Horn, Paul ^e   Elkashef, Ahmed ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Cincinnati Addictions Research Center CinARC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Clinical trials; Cocaine dependence; Outcome measures; SRPHK1; Urine toxicology

Indexed keywords

BENZOYLECGONINE; COCAINE; PLACEBO; RESERPINE; TIAGABINE;

ADULT; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT OUTCOME; URINALYSIS;

ADULT; COCAINE; COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PROTEIN-SERINE-THREONINE KINASES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 36849081857     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.09.007     Document Type: Article

References (25)

1. Arrestee Drug Abuse Monitoring (ADAM) program report. National Institute of Justice. (accessed in 2006).
2. Ambre J.J. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data. J. Anal. Toxicol. 9 (1985) 241-245
3. Ambre J., Ruo T.I., Nelson J., and Belknap S. Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans. J. Anal. Toxicol. 12 (1988) 301-306
4. Batki S.L., Manfredi L.B., Jacob P., and Jones R.T. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J. Clin. Psychopharmacol. 13 (1993) 243-250
5. Crosby R.D., Halikas J.A., and Bowers L.D. Quantitative cocaine urine testing in clinical research settings. Ann. Clin. Psychiatry 244 (1991) 243-249
6. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., and Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 68 (2000) 134-144
7. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview of Axis I DSM-IV Disorders-Patient Edition (With Psychotic Screen) (SCID-I/P w/Psychotic Screen, Version 2.0) (1996), Biometrics Research Department, New York State Psychiatric Institute, New York
8. Hamilton H.E., Wallace J.E., Shimak E.L., Land P., Harris S.C., and Christenson J.G. Cocaine and benzoylecgonine excretion in humans. J. Forensic Sci. 22 (1977) 697-707
9. Jufer R., Walsh S.L., Cone E.J., and Sampson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. J. Anal. Toxicol. 30 (2006) 458-462
10. Lavori P.W., Bloch D.A., Bridge P.T., Leiderman D.B., LoCastro J.S., and Somoza E. Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDA/VA/SU Working Group on Design and Analysis. J. Clin. Psychopharmacol. 19 (1999) 246-256
11. Li S.-H., Chiang C.N., Tai B.C., Marschke C.K., and Hawks R.L. Qualitative versus qualitative urinalysis of benzoylecgonine in clinical trials for the assessment of cocaine use. Psychopharmacol. Bull. 31 (1995) 671-679
12. Liang K.-Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
13. Little R.J.A., and Rubin D.B. Statistical Analysis with Missing Data (1987), John Wiley & Sons, New York
14. Little R.J.A. Modeling the drop-out mechanism in repeated-measures studies. J. Am. Stat. Assoc. 90 (1995) 1112-1121
15. McCoy C.B., Lai S., Metsch L.R., Messiah S.E., and Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infections. Ann. Epidemiol. 14 (2004) 535-542
16. Myers W.R. Handling missing data in clinical trials: an overview. Drug Inf. J. 34 (2000) 525-533
17. Preston K.L., Silverman K., Schuster C.R., and Cone E.J. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 92 (1997) 717-727
18. Sobell L.C., and Sobell M.B. Timeline follow back: a technique for assessing self-reported ethanol consumption. In: Allen J., and Lit-ten R. (Eds). Techniques to Assess Alcohol Consumption (1992), Humana Press, Inc., New Jersey 19-28
19. Somoza E., Somoza P., Lewis D., Li S., Elkashef A., Vocci F., and Winhusen T. Survey and exploratory evaluation of outcome measures used in efficacy studies of treatments for cocaine abuse. Poster Presented at the 66th Annual Meeting on the College on Problems of Drug Dependence. San Juan, Puerto Rico (2004)
20. Substance Abuse and Mental Health Services Administration, 2006a. DAWN Series D-28, DHHS Publication No. (SMA) 06-4143. Rockville, MD. (accessed in 2006).
21. Substance Abuse and Mental Health Services Administration, 2006b. Results from the 2005 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. (SMA) 06-4194. Rockville, MD.
22. Vocci F., and Ling W. Medications development: successes and challenges. Pharmacol. Ther. 108 (2005) 94-108
23. Winhusen T., Somoza E., Sarid-Segal O., Goldsmith R.J., Harrer J.M., Coleman F.S., Kahn R., Osman S., Mezinskis J., Li S., Lewis D., Afshar M., Ciraulo D.A., Horn P., Montgomery M.A., and Elkashef A. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence. Drug Alcohol Depend 91 (2007) 205-212 10.1016/j.drugalcdep.2007.05.021
24. Winhusen T., Somoza E., Sarid-Segal O., Goldsmith R.J., Harrer J.M., Coleman F.S., Kahn R., Osman S., Mezinskis J., Li S., Lewis D., Afshar M., Ciraulo D.A., Horn P., Montgomery M.A., and Elkashef A. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug Alcohol Depend 91 (2007) 141-148 10.1016/j.drugalcdep.2007.05.028
25. Zeger S.L., and Liang K.-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130